Page last updated: 2024-10-29

imipramine and Facial Dermatoses

imipramine has been researched along with Facial Dermatoses in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Facial Dermatoses: Skin diseases involving the FACE.

Research Excerpts

ExcerptRelevanceReference
"We describe a patient with facial pigmentation of 26 years' duration that was associated with imipramine treatment for depression."3.73Imipramine-induced facial pigmentation: case report and literature review. ( Lin, AN; Metelitsa, AI; Nguyen, GK, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Metelitsa, AI1
Nguyen, GK1
Lin, AN1
Hashimoto, K1
Joselow, SA1
Tye, MJ1

Other Studies

2 other studies available for imipramine and Facial Dermatoses

ArticleYear
Imipramine-induced facial pigmentation: case report and literature review.
    Journal of cutaneous medicine and surgery, 2005, Volume: 9, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Facial Derm

2005
Imipramine hyperpigmentation: a slate-gray discoloration caused by long-term imipramine administration.
    Journal of the American Academy of Dermatology, 1991, Volume: 25, Issue:2 Pt 2

    Topics: Adult; Cytoplasmic Granules; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imipramine; Inclusi

1991